Fransi Capital recommends Mobily’s share retention with a target price of SAR 58/share

23/11/2014 Argaam

Saudi Fransi Capital reviewed its recommendation for Mobily’s shares to retention after the adjustments made by Mobily’s management for Q3’s profit.
 

Fransi Capital upgraded its recommendations to purchase for the shares of Dallah Health Care because of its high earnings per share,

Najran Cement for strong sales growth and Yanbu Cement due to the high dividends distributed while it affirmed its recommendation to purchase Arabian Cement’s shares because of sales growth.

 

 

Saudi Fransi Capital recommendations

Target price

previous recommendation

recommendation

Company

144

retention

buy

Dallah Healthcare Holding Company

58

Under revision

retention

Mobily

81

retention

buy

Yanbu Cement

33

retention

buy

Najran Cement

95

buy

buy

Arabian Cement Company

15

retention

retention

Chemanol

13.5

retention

retention

Kayan

         
 

 

 

 

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.